Investors Research Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.3K Buy
+21
New +$24.8K ﹤0.01% 450
2024
Q1
– Sell
-6
Closed -$3.5K – 1067
2023
Q4
$3.5K Buy
+6
New +$3.5K ﹤0.01% 884
2023
Q2
– Sell
-1,780
Closed -$611K – 1107
2023
Q1
$611K Hold
1,780
– – 0.16% 171
2022
Q4
$651K Hold
1,780
– – 0.18% 164
2022
Q3
$576K Hold
1,780
– – 0.18% 161
2022
Q2
$577K Sell
1,780
-100
-5% -$30K 0.17% 173
2022
Q1
$538K Buy
1,880
+16
+0.9% +$4.12K 0.15% 185
2021
Q4
$515K Hold
1,864
– – 0.16% 175
2021
Q3
$431K Hold
1,864
– – 0.15% 193
2021
Q2
$428K Buy
1,864
+100
+6% +$20.1K 0.15% 193
2021
Q1
$330K Hold
1,764
– – 0.12% 228
2020
Q4
$298K Hold
1,764
– – 0.12% 243
2020
Q3
$261K Hold
1,764
– – 0.13% 239
2020
Q2
$290K Hold
1,764
– – 0.15% 210
2020
Q1
$245K Hold
1,764
– – 0.15% 218
2019
Q4
$232K Hold
1,764
– – 0.11% 263
2019
Q3
$197K Buy
1,764
+93
+6% +$10.4K 0.1% 266
2019
Q2
$185K Hold
1,671
– – 0.1% 267
2019
Q1
$217K Buy
+1,671
New +$203K 0.12% 242

Other funds holding LLY

Investors Research Corp's LLY Position: Q3 2026 in Review

Investors Research Corp opened a new position in Eli Lilly (LLY) in Q3 2026: 21 shares worth $24.3K. The stake represents ﹤0.01% of the portfolio and ranks #450 among its holdings. This is a return to the name: Investors Research Corp previously reported a position in LLY as recently as Q4 2023.

Investors Research Corp first reported a position in LLY in Q1 2019 and has held it in 19 quarters since. The position peaked at $651K in Q4 2022. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Investors Research Corp held 21 shares of Eli Lilly worth $24.3K as of Q3 2026.
  • Eli Lilly was a new Investors Research Corp position in Q3 2026.
  • Eli Lilly made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #450 holding.
  • Investors Research Corp first reported a position in Eli Lilly in Q1 2019 and has held it in 19 quarters since.
  • Investors Research Corp's Eli Lilly position peaked at $651K in Q4 2022.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.